Hypotensive anaesthesia 5 mark answer

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive content from Morgan & Mikhail's Clinical Anesthesiology. Let me compile the complete 5-mark answer.

Hypotensive Anaesthesia

Definition

Hypotensive (controlled) anaesthesia is the deliberate, elective lowering of arterial blood pressure during surgery to a safe but haemodynamically controlled level in order to reduce intraoperative blood loss and improve the surgical field. - Morgan and Mikhail's Clinical Anesthesiology, 7e, p. 475

Indications (Procedures Benefitting Most)

  • Cerebral aneurysm repair (reduces transmural tension, prevents rupture/rebleeding, facilitates clipping)
  • Brain tumour resection
  • Total hip arthroplasty
  • Radical neck dissection
  • Radical cystectomy
  • Major spinal surgery (scoliosis correction, etc.)
  • Ear surgery (middle ear, stapes surgery) - reduces ooze in the operative field
  • Endoscopic sinus surgery (FESS) - target MAP ~90 mmHg (systolic) or HR ~60 bpm
  • Operations with expected major haemorrhage

Target Blood Pressure

  • Healthy young adults: MAP can be lowered to 50-60 mmHg safely
  • Chronically hypertensive patients: should not drop more than 20-30% below baseline
  • Patients with a history of TIAs may not tolerate any reduction in cerebral perfusion pressure
  • Recent evidence suggests the lower limit of cerebral autoregulation may be higher than previously assumed; hence use of this technique is declining

Methods of Achieving Controlled Hypotension

Non-Pharmacological

  • Neuraxial anaesthesia (spinal/epidural) - reduces SVR and sympathetic tone
  • Elevation of the surgical site - selectively reduces BP at the wound
  • Positive-pressure ventilation (PPV) - increases intrathoracic pressure, impedes venous return, lowers cardiac output and MAP

Pharmacological Agents

AgentMechanism
Volatile anaesthetics (isoflurane, sevoflurane)Reduce SVR; note - may paradoxically worsen nasal field in FESS by vasodilating nasal microvasculature
Sodium nitroprusside (SNP)Peripheral vasodilator; rapid onset/offset; risk of cyanide toxicity with prolonged use
NitroglycerinPredominantly venodilator; reduces preload
Beta-blockers (esmolol, labetalol)Reduce HR and cardiac output; preferred in FESS - HR ~60 bpm is the target
Calcium channel blockersReduce SVR
Remifentanil (short-acting opioid)Used in TIVA protocols; reduces HR and MAP
Sympathetic antagonists (ganglionic blockers)Reduce sympathetic outflow

Contraindications (Relative)

  • Severe anaemia (already reduced O2-carrying capacity)
  • Hypovolaemia
  • Atherosclerotic cardiovascular disease
  • Renal or hepatic insufficiency
  • Cerebrovascular disease
  • Uncontrolled glaucoma (raised IOP worsens with hypotension)

Complications

  • Cerebral thrombosis / stroke
  • Hemiplegia (decreased spinal cord perfusion)
  • Acute tubular necrosis (renal ischaemia)
  • Massive hepatic necrosis
  • Myocardial infarction
  • Cardiac arrest
  • Blindness - retinal artery thrombosis or ischaemic optic neuropathy (especially in prone spine surgery)
  • Risk is amplified in patients with coexisting anaemia
  • Patients in beach chair / sitting position (shoulder surgery) are at particular risk for cerebral hypoperfusion and perioperative infarction

Monitoring

  • Intra-arterial BP monitoring - transducer zeroed at the level of the external auditory meatus (level of the circle of Willis) to accurately measure cerebral perfusion pressure
  • Cerebral oximetry (NIRS) - recommended when hypotensive anaesthesia is used
  • ECG, pulse oximetry, urine output, temperature monitoring as standard

Key Points (Summary)

  1. Hypotensive anaesthesia = elective lowering of BP to minimise blood loss and optimise the surgical field
  2. Safe MAP target: 50-60 mmHg in healthy patients; no more than 20-30% reduction from baseline in hypertensives
  3. Achieved by neuraxial block, patient positioning, volatile agents, vasodilators (SNP), beta-blockers, or remifentanil-based TIVA
  4. Relative contraindications include cerebrovascular, cardiovascular, renal, and hepatic disease
  5. Complications range from cerebral ischaemia and MI to renal failure and blindness; incidence declining as safer alternatives are available
Source: Morgan and Mikhail's Clinical Anesthesiology, 7e, pp. 475-476; Scott-Brown's Otorhinolaryngology Head & Neck Surgery, Vol 1 & 2
This is a shared conversation. Sign in to Orris to start your own chat.